Magrath George 4
4 · Opus Genetics, Inc. · Filed Jul 27, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics (IRD) CEO George Magrath Sells 9,475 Shares
What Happened
George Magrath, Chief Executive Officer of Opus Genetics, sold 9,475 shares on July 23, 2026 in an open-market/private sale. The weighted-average sale price was $2.95 per share (range $2.9009–$3.025), for proceeds of approximately $27,926. This disposition was executed to satisfy tax withholding obligations tied to a restricted stock unit (RSU) vesting event and was not a discretionary trade by the CEO.
Key Details
- Transaction type: Sale (reported as S); transaction date: 2026-07-23; filing date: 2026-07-27.
- Price: Weighted average $2.95; individual trade prices ranged from $2.9009 to $3.025. The filer offered to provide a price-by-price breakdown on request (Footnote F2).
- Reason/footnote: Sold automatically to satisfy tax withholding from an RSU vesting/settlement (Footnote F1). Not a voluntary market-timing sale.
- Shares owned after transaction: Not specified in the provided filing.
- Timeliness: Filed 2026-07-27; based on the reported dates this appears to meet the Form 4 two-business-day filing requirement.
Context
This was a tax-withholding sale tied to equity compensation (RSUs), a common administrative transaction that does not necessarily reflect the insider’s view on the company’s stock. Purchases are typically more informative about insider confidence; this sale appears routine.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-07-23$2.95/sh−9,475$27,926→ 1,731,869 total
Footnotes (2)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
- [F2]The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9009 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.